Subscriptions: Want to stay updated? Click here to subscribe to our press releases
Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Mar | Feb  | Jan

	Dr. Reddy's Laboratories and Leiner Health Products sign exclusive 15-year OTC product development and marketing agreement; Dr. Reddy's CEO to join Leiner's Board of Directors February 24, 2003
	Dr. Reddy's files lawsuit against Pfizer regarding Sertraline ANDA February 24, 2003
	Novo Nordisk to move forward on development of Dr. Reddy's Balaglitazone (DRF 2593); Not to pursue further development of Ragaglitazar (DRF 2725) February 6, 2003

The information contained in the releases was current on the date they were issued and will become or may have become outdated over time. Dr. Reddy's does not assume any responsibility for updating
information in the releases.